Ben Venue Laboratories, a Bedford, Ohio-based subsidiary of German drugmaker Boehringer Ingelheim has tapped Bank of America Merrill Lynch to explore a possible sale of its generic sterile injectable drugs business. Ben Venue announced in October that it was ceasing production due to quality control issues and said it was "exploring strategic options" for its Bedford Laboratories business. The firm has hired Bank of America "to educate potential buyers about the Bedford Laboratories business" and the Ben Venue manufacturing site, a Boehringer spokeswoman wrote in an email on Tuesday.
Help employers find you! Check out all the jobs and post your resume.
